Experimental models for respiratory syncytial virus infections

Reviews and Research in Medical Microbiology

Volumn 7, Issue 2, 1996, Pages 115-122

  Kimpen, J L L ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Animal models; Cell culture; Immunopathogenesis; Respiratory syncytial virus

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; B LYMPHOCYTE; CELL CULTURE; CELL TYPE; EOSINOPHIL; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MACROPHAGE; METHODOLOGY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; T LYMPHOCYTE; VACCINATION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS VIRULENCE;

EID: 0029873597     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-199604000-00006     Document Type: Review

References (59)

1. Glezen WP, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973; 288: 498-505.
2. Ruuskanen O, Ogra PL. Respiratory syncyrial virus. Curr Probl Pediatr 1993; 23: 50-79.
3. Pullan CR, Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J 1982; 284: 1665-1669.
4. Kimpen JLL, Heymans HSA. Respiratory syncytial virus: immunity and immune injury. Immunol Infect Dis 1993; 3: 281-288.
5. Kim HW, Canchola JG, Brandt CD et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969; 89: 422-434.
6. Openshaw PJM, O'Donnell DR. Asthma and the common cold: can viruses imitate worms? Thorax 1994; 49: 101-103.
7. Bächi T, Howe C. Morphogenesis and ultrastructure of respiratory syncytial virus. J Virol 1973; 12: 1173-1180.
8. Collins PL, Huang YT, Wertz GW. Identification of a tenth mRNA of respiratory syncytial virus and assignment of polypeptides to the 10 viral genes. J Virol 1984; 49: 572-578.
9. Kimpen JLL, Rich GA, Mohar CK, Ogra PL. Mucosal T cell distribution during infection with respiratory syncytial virus. J Med Virol 1992; 36: 172-179.
10. Panuska JR, Cirino NM, Midulla F, Despot JE, McFadden ER Jr, Huang YT. Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J Clin Invest 1990; 86: 113-119.
11. Domurat F, Roberts NJ Jr, Walsh EE, Dagan R. Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo. J Infect Dis 1985; 152: 895-902.
12. Midulla F, Villani A, Panuska JR et al. Respiratory syncytial virus lung infection in infants: Immunoregulatory role of infected alveolar macrophages. J Infect Dis 1993; 168: 1515-1519.
13. Storch GA, Park CS, Dohner DE. RNA fingerprinting of respiratory syncytial virus using ribonuclease protection. Application to molecular epidemiology. J Clin Invest 1989; 83: 1894-1902.
14. Anderson LJ, Hierholzer JC, Tsou C et al. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis 1985; 151: 626-633.
15. Sullender WM, Sun L, Anderson LJ. Analysis of respiratory syncytial virus genetic variability with amplified cDNAs. J Clin Microbiol 1993; 31: 1224-1231.
16. Anderson K, Stott EJ, Wertz GW. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage. J Gen Virol 1992; 73: 1177-1188.
17. Kulkarni AB, Collins PL, Bacik I et al. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J Virol 1995; 69: 1261-1264.
18. Wathen MW, Brideau RJ, Thomsen DR, Murphy BR. Characterization of a novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector. J Gen Virol 1989; 70: 2625-2635.
19. Prince GA, Horswood RL, Berndt J, Suffin SC, Chanock RM. Respiratory syncytial virus infection in inbred mice. Infect Immun 1979; 26: 764-766.
20. Wong DT, Rosenband M, Hovey K, Ogra PL. Respiratory syncytial virus infection in immunosuppressed animals: implications in human infection. J Med Virol 1985; 17: 359-370.
21. Graham BS, Bunton LA, Rowland J, Wright PF, Karzon DT. Respiratory syncytial virus infection in anti-μ-treated mice. J Virol 1991; 65: 4936-4942.
22. Becker S, Soukup J, Yankaskas JR. Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages. Am J Respir Cell Mol Biol 1992; 6: 369-374.
23. Arnold R, Humbert B, Werchau H, Gallati H, Koenig W. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 1994; 82: 126-133.
24. Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol Lung Cell Mol Physiol 1993; 265: L472-478.
25. Franke-Ullmann G, Pfoertner C, Walter P, et al. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. J Immunol 1995; 154: 268-280.
26. Roberts NJ Jr, Prill AH, Mann TN. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. J Exp Med 1986; 163: 511-519.
27. Becker S, Quay J, Soukup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 1991; 147: 4307-4312.
28. Faden H, Kaul TN, Ogra PL. Activation of oxidative and arachidonic acid metabolism in neutrophils by respiratory syncytial virus antibody complexes: possible role in disease. J Infect Dis 1983; 148: 110-116.
29. Faden H, Hong JJ, Ogra PL. Interaction of polymorphonuclear leukocytes and viruses in humans: adherence of polymorphonuclear leukocytes to respiratory syncytial virus-infected cells. J Virol 1984; 52: 16-23.
30. Arnold R, Werner F, Humbert B, Werchau H, Koenig W. Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-α) release and respiratory burst in human granulocytes. Immunology 1994; 82: 184-191.
31. Kimpen JLL, Garofalo R, Welliver RC, Ogra PL. Activation of human eosinophils in vitro by respiratory syncytial virus. Pediatr Res 1992; 32: 160-164.
32. Okamoto Y, Brodsky L, Bernstein JM, Ogra PL. Characteristics of in vitro production of mucosal antibody to respiratory syncytial virus in tonsillar tissue lymphocytes. Clin Immunol Immunopathol 1988; 49: 299-307.
33. Cannon MJ, Openshaw PJM, Askonas BA. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 1988; 168: 1163-1168.
34. Alwan WH, Record FM, Openshaw PJM. Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. J Immunol 1993; 150: 5211-5218.
35. Cherrie AH, Anderson K, Wertz GW, Openshaw PJM. Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K and 1b proteins of respiratory syncytial virus. J Virol 1992; 66: 2102-2110
36. Anderson LJ, Tsou C, Potter C et al. Cytokine response to respiratory syncytial virus stimulation of human peripheral mononuclear cells. J Infect Dis 1994; 170: 1201-1208.
37. Prince GA, Jenson AB, Horswood RL, Camargo E, Chanock RM. The pathogenesis of respiratory syncytial virus infection in cotton rats. Am J Pathol 1978; 93: 771-792.
38. Taylor G, Stott EJ, Hughes M, Collins AP. Respiratory syncytial virus infection in mice. Infect Immun 1984; 43: 649-655.
39. Kanesaki T, Murphy BR, Collins PL, Ogra PL. Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus. J Virol 1991; 65: 657-663.
40. Anderson JJ, Norden J, Saunders D, Toms GL, Scott R. Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection. J Gen Virol 1990; 71: 1561-1570.
41. Nadal D, Albini B, Schlaepfer E, Chen C, Brodksky L, Ogra PL. Tissue distribution of mucosal antibody-producing cells specific for respiratory syncytial virus in severe combined immune deficiency (SCID) mice engrafted with human tonsils. Clin Exp Immunol 1991; 85: 358-364.
42. Openshaw PJM. Flow cytometric analysis of pulmonary lymphocytes from mice infected with respiratory syncytial virus. Clin Exp Immunol 1989; 75: 324-328.
43. Kimpen JLL, Ogra PL. T cell redistribution kinetics after secondary infection of BALB/c mice with respiratory syncytial virus. Clin Exp Immunol 1993; 91: 78-82.
44. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991; 88: 1026-1033.
45. + T cells. Clin Exp Immunol 1992; 88: 527-536.
46. Connors M, Collins PL, Firestone C-Y, Murphy BR. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J Virol 1991; 65: 1634-1637.
47. + T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies. J Virol 1992; 66: 1277-1281.
48. Openshaw PJM, Clarke SL, Record FM. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int Immunol 1992; 4: 493-500.
49. Kaul TN, Welliver RC, Wong DT, Udwadia RA, Riddlesberger K, Ogra PL. Secretory antibody response to respiratory syncytial virus infection. Am J Dis Child 1981; 135: 1013-1016.
50. Welliver RC, Kaul TN, Putman TI, Sun M, Ogra PL. The antibody response to primary and secondary infection with respiratory syncytial virus: Kinetics of class-specific responses. J Pediatr 1980; 96: 808-813.
51. Welliver RC, Kaul TN, Ogra PL. The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. N Engl J Med 1980; 303: 1198-1202.
52. Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995; 171: 584-592.
53. Garofalo R, Kimpen JLL, Welliver RC, Ogra PL. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992; 120: 28-32.
54. Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981; 305: 841-846.
55. Groothuis JR, Simoes EAF, Levin MJ et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 1993; 329: 1524-1530.
56. Springer C, Bar-Yishay E, Uwayyed K, Avital A, Vilozni D, Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol 1990; 9: 181-185.
57. Graham BS, Henderson GS, Tang Y-W, Lu X, Neuzil KM, Colley DG. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 1993; 151: 2032-2040.
58. Connors M, Giese NA, Kulkarni AB, Firestone C-Y, Morse HC III, Murphy BR. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-1) and IL-10. J Virol 1994; 68: 5321-5325.
59. Wathen MW, Kakuk TJ, Brideau RJ, Hausknecht EC, Cole SL, Zaya RM. Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge. J Infect Dis 1991; 163: 477-482.